Cargando…

Pegylated Liposomal Doxorubicin-induced Palmar-plantar Erythrodysesthesia

Detalles Bibliográficos
Autores principales:	Moreira-Barros, Joana, Huang, Kuan-Gen, Tsai, Tsung-Hsun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2018
Materias:	Clinical Image
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135151/ https://www.ncbi.nlm.nih.gov/pubmed/30254936 http://dx.doi.org/10.4103/GMIT.GMIT_8_17

Ejemplares similares

Docetaxel induced severe palmar plantar erythrodysesthesia
por: Kharmoum, Saoussane, et al.
Publicado: (2018)

Paclitaxel-Induced Palmar-Plantar Erythrodysesthesia
por: Wahab, Ahsan, et al.
Publicado: (2020)

Liposomal doxorubicin-related palmar–plantar erythrodysesthesia (hand–foot syndrome): a case report
por: Ni, Chenxu, et al.
Publicado: (2020)

Palmar-Plantar Erythrodysesthesia Associated with Chemotherapy and Its Treatment
por: Farr, Katherina Podlekareva, et al.
Publicado: (2011)

Palmar-plantar erythrodysesthesia: An uncommon adverse effect of everolimus
por: Arora, Shalabh, et al.
Publicado: (2016)

Palmar-plantar erythrodysesthesia secondary to docetaxel chemotherapy: a case report
por: Benghiat, Helen, et al.
Publicado: (2011)

Palmar-plantar erythrodysesthesia associated with capecitabine chemotherapy: a case report
por: Kigen, Gabriel, et al.
Publicado: (2015)

Palmar-plantar Erythrodysesthesia with Genital Involvement Secondary to Capecitabine Chemoradiotherapy: A Case Report
por: Hu, Hsin-pei, et al.
Publicado: (2018)

Elephant leg after treatment for endometrial cancer
por: Moreira-Barros, Joana, et al.
Publicado: (2017)

Pegylated liposomal doxorubicin for myeloid neoplasms
por: Zhang, Cheng, et al.
Publicado: (2019)

Palmar–plantar erythrodysesthesia syndrome resulting from toceranib phosphate in a dog with apocrine gland anal sac adenocarcinoma: a case report
por: Kim, Eunjoo, et al.
Publicado: (2023)

Plantar Erythrodysesthesia Caused by Antiretroviral Treatment: A Case Report and Review of the Literature
por: Aigner, B., et al.
Publicado: (2013)

Eczema Palmare and Plantare
por: Jamieson, W. Allan
Publicado: (1898)

Eczema Palmare and Plantare
por: Jamieson, W. Allan
Publicado: (1898)

Pegylated liposomal doxorubicin in ovarian cancer
por: Green, Andrew E, et al.
Publicado: (2006)

Pegylated liposomal doxorubicin in ovarian cancer
por: Strother, Robert, et al.
Publicado: (2009)

Plantar erythrodysesthesia with bullous otitis externa, toxicities from sorafenib: a case report
por: Carter, Corey A, et al.
Publicado: (2009)

Phase I study of pegylated liposomal doxorubicin and the multidrug-resistance modulator, valspodar
por: Fracasso, P M, et al.
Publicado: (2005)

Pegylated liposomal doxorubicin in the management of ovarian cancer
por: Ferrandina, Gabriella, et al.
Publicado: (2010)

A tale of the two PEGylated liposomal doxorubicins
por: Chou, Hunghsueh, et al.
Publicado: (2015)

Radiation-Induced Uterine Carcinosarcoma after Concurrent Chemoradiotherapy for Cervical Squamous Cell Carcinoma
por: Moreira-Barros, Joana, et al.
Publicado: (2018)

Palmar and plantar fibromatosis: a review
por: Stewart, Brian D., et al.
Publicado: (2021)

Anthracycline-induced toxicity affecting palmar and plantar skin.
por: Jones, A. P., et al.
Publicado: (1989)

Prolonged use of pegylated liposomal doxorubicin in gynecologic malignancies
por: Yost, S., et al.
Publicado: (2019)

Pegylated liposomal doxorubicin in patients with epithelial ovarian cancer
por: Yuan, Zhen, et al.
Publicado: (2021)

Impact of PEGylated Liposomal Doxorubicin and Carboplatin Combination on Glioblastoma
por: Ghaferi, Mohsen, et al.
Publicado: (2022)

Effect of Apatinib Plus Pegylated Liposomal Doxorubicin vs Pegylated Liposomal Doxorubicin Alone on Platinum-Resistant Recurrent Ovarian Cancer: The APPROVE Randomized Clinical Trial
por: Wang, Tiantian, et al.
Publicado: (2022)

Treatment of inoperable hepatocellular carcinoma with pegylated liposomal doxorubicin (PLD): results of a phase II study
por: Valle, J W, et al.
Publicado: (2005)

A phase I study of pegylated liposomal doxorubicin and temsirolimus in patients with refractory solid malignancies
por: Wang-Gillam, Andrea, et al.
Publicado: (2014)

Cardiac safety of trabectedin monotherapy or in combination with pegylated liposomal doxorubicin in patients with sarcomas and ovarian cancer
por: Jones, Robin L., et al.
Publicado: (2021)

Pegylated liposomal doxorubicin in the treatment of AIDS-related Kaposi’s sarcoma
por: Udhrain, Ashish, et al.
Publicado: (2007)

Clinical Trials with Pegylated Liposomal Doxorubicin in the Treatment of Ovarian Cancer
por: Pisano, Carmela, et al.
Publicado: (2013)

Erythrodysesthesia: An Unusual Complication With Trastuzumab Monotherapy
por: Fontenot, Andee L, et al.
Publicado: (2021)

Palmar rash in a teenager: more than meets the eye
por: Sousa, Rodrigo, et al.
Publicado: (2016)

Cost-minimisation analysis of pegylated liposomal doxorubicin hydrochloride versus topotecan in the treatment of patients with recurrent epithelial ovarian cancer in Spain
por: Ojeda, B, et al.
Publicado: (2003)

A phase I dose-finding study of a combination of pegylated liposomal doxorubicin (Doxil), carboplatin and paclitaxel in ovarian cancer
por: Gibbs, D D, et al.
Publicado: (2002)

CIRCUMSCRIBED PALMAR OR PLANTAR HYPOKERATOSIS: REPORT OF AN ITALIAN CASE
por: Tosi, D, et al.
Publicado: (2011)

A Family with Palmar and Plantar Hyperkeratosis: A Quiz
por: JURATLI, Hazem A., et al.
Publicado: (2020)

Modeling pegylated liposomal doxorubicin-induced hand-foot syndrome and intestinal mucositis in zebrafish
por: Chen, Yau-Hung, et al.
Publicado: (2014)

Serious stomatitis and esophagitis: a peculiar mucous reaction induced by pegylated liposomal doxorubicin
por: Ma, Han, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ft23esohep8v6acpfam6f5usp7